80 related articles for article (PubMed ID: 2839322)
1. Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM.
Moore MP; Elliott TW; Nicholls MG
Diabetes Care; 1988 May; 11(5):397-401. PubMed ID: 2839322
[TBL] [Abstract][Full Text] [Related]
2. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
Ueda Y; Aoi W; Yamachika S; Shikaya T
Nephron; 1990; 55 Suppl 1():85-9. PubMed ID: 2189076
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
Baba T; Murabayashi S; Takebe K
Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
[TBL] [Abstract][Full Text] [Related]
5. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
7. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
8. Effects of enalapril and nitrendipine on the excretion of epidermal growth factor and albumin in hypertensive NIDDM patients.
Josefsberg Z; Ross SA; Lev-Ran A; Hwang DL
Diabetes Care; 1995 May; 18(5):690-3. PubMed ID: 8586009
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.
Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
Diabetes Care; 1991 Oct; 14(10):911-4. PubMed ID: 1773691
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic effects of berlipril-5 in patients with non-insulin dependent diabetes mellitus and arterial hypertension].
Ametov AS; Gubina EV
Ter Arkh; 1999; 71(10):22-5. PubMed ID: 10612168
[TBL] [Abstract][Full Text] [Related]
11. [Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus].
Zonis BIa; Volkova NI; Sokolov OIu
Ter Arkh; 2000; 72(2):53-5. PubMed ID: 10717928
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
[TBL] [Abstract][Full Text] [Related]
13. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz HE; Wiegmann TB; Cnaan A; Shahinfar S; Sica DA; Broadstone V; Schwartz SL; Mengel MC; Segal R; Versaggi JA
Kidney Int Suppl; 1994 Feb; 45():S150-5. PubMed ID: 8158885
[TBL] [Abstract][Full Text] [Related]
14. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
15. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.
Vuorinen-Markkola H; Yki-Järvinen H
Metabolism; 1995 Jan; 44(1):85-9. PubMed ID: 7854171
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure response to angiotensin converting enzyme inhibitor in essential hypertension: its relation to the renin status and natriuresis during acute sodium loading.
Hou CH; Chen YM; Wu KD; Hsieh BS
J Formos Med Assoc; 1993 Nov; 92(11):942-7. PubMed ID: 7910063
[TBL] [Abstract][Full Text] [Related]
18. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
19. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
Reams GP; Lal SM; Whalen JJ; Bauer JH
J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
[TBL] [Abstract][Full Text] [Related]
20. Enalapril versus combined enalapril and nadolol treatment: effects on blood pressure, heart rate, humoral variables, and plasma potassium at rest and during exercise in hypertensive patients.
Sullivan PA; Daly B; O'Connor R
Cardiovasc Drugs Ther; 1992 Jun; 6(3):261-5. PubMed ID: 1637731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
